Formulary
Ponatinib [Specialist drug]: Indications, Dosing, Side Effects and Interactions
Ponatinib [Specialist drug] clinical drug profile including indications, dosing, side effects, cautions and interactions.
MedNext Academy | 3 min read
Ponatinib [Specialist drug]: Indications, Dosing, Side Effects and Interactions
Ponatinib [Specialist drug] clinical drug profile including indications, dosing, side effects, cautions and interactions.
Indications and dose
**Chronic myeloid leukaemia,Acute lymphoblastic leukaemia**
- **Adult** (By Mouth): Specialist drug - access specialist resources for dosing information.
Side effects
For ponatinib [Specialist drug] Common or very common Acute coronary syndrome; alopecia; anaemia; appetite decreased; arrhythmias; arthralgia; asthenia; cerebrovascular insufficiency; chills; constipation; cough; diarrhoea; dizziness; dry eye; dry mouth; dysphonia; dyspnoea; electrolyte imbalance; embolism and thrombosis; erectile dysfunction; eye inflammation; fever; fluid imbalance; gastrointestinal discomfort; gastrooesophageal reflux disease; haemorrhage; headaches; heart failure; hyperglycaemia; hypertension; hypertriglyceridaemia; hyperuricaemia; hypothyroidism; increased risk of infection; influenza like illness; insomnia; ischaemic heart disease; lethargy; mass; muscle complaints; nausea; neutropenia; oedema; pain; pancreatitis; pancytopenia; pericardial effusion; peripheral neuropathy; peripheral vascular disease; pleural effusion; pulmonary hypertension; sensation abnormal; sepsis; skin reactions; stomatitis; sweat changes; vasodilation; vision disorders; vomiting; weight decreased Uncommon Cardiac discomfort; cardiomyopathy ischaemic; coronary vasospasm; hepatic disorders; hepatic failure (including fatal cases); intracranial haemorrhage; left ventricular dysfunction; posterior reversible encephalopathy syndrome (PRES); renal artery stenosis; splenic infarction; tumour lysis syndrome Rare or very rare Panniculitis Frequency not known Acute kidney injury; aneurysm; artery dissection; thrombocytopenia Side-effects, further information Heart failure If signs and symptoms of heart failure develop, withhold treatment; consider stopping treatment if severe heart failure develops. Thromboembolism Withhold treatment immediately if arterial occlusion or thromboembolism suspected.
Medicinal forms
Clinical governance
**Author:** MedNext Clinical Team. **Clinical reviewer:** Dr Shameer Deen, MBBS, MS, MRCS. **Sources:** BNF, Indian Pharmacopoeia, CIMS India. **Correction:** Report errors at support@mednext.academy.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- Growing visual cheat sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Subject HubPharmacology Hub
All pharmacology resources in one place.
Drug SchedulesIndian Drug Schedules
Schedule H, H1, X and G classifications.
FormularyBrowse all drugs
Search 1,850+ drug profiles.
Study Ponatinib [Specialist drug] in the MedNext app
Challenge yourself with targeted pharmacology MCQs on this drug class. Every explanation links back to the chapter that teaches the concept.
Start drug challengeExplore the full formulary

